| May 31 |
Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal
|
| May 31 |
Ultragenyx (RARE) DTX401 Meets Goals in Metabolic Disorder Study
|
| May 29 |
AstraZeneca (AZN) Falls on Failure to Meet NSCLC Study OS Goal
|
| May 29 |
Prothena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate
|
| May 29 |
ALX Oncology Announces Participation in the Jefferies Global Healthcare Conference
|
| May 28 |
Candel (CADL) Stock Skyrockets 431% Year to Date: Here's Why
|
| May 27 |
Apellis (APLS) Posts Upbeat One-Year Kidney Diseases Study Data
|
| May 24 |
Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data
|
| May 24 |
Bicycle Therapeutics (BCYC) Up as PIPE Funding Set to Make $555M
|
| May 23 |
Deciphera's (DCPH) Shares Surge 74.3% in a Month: Here's Why
|
